Olivia O'CONNOR

Mrs. Olivia O'CONNOR

Institut Pasteur de Nouvelle-Calédonie
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Emerging Infectious Diseases
Verified
Journal Article
Open access
AGAnn-Claire Gourinat
Ann-Claire Gourinat
OOOlivia O'CONNOR
Olivia O'CONNOR
ECElodie Calvez
Elodie Calvez
CGCyrille Goarant
Cyrille Goarant
MDMyrielle Dupont-Rouzeyrol
Myrielle Dupont-Rouzeyrol
We describe the kinetics of Zika virus (ZIKV) detection in serum and urine samples of 6 patients. Urine samples were positive for ZIKV >10 days after onset of disease, which was a notably longer period than for serum samples. This finding supports the conclusion that urine samples are useful for diagnosis of ZIKV infections.

1 February 2015 in Emerging Infectious Diseases
Verified
Journal Article
Open access
MDMyrielle Dupont-Rouzeyrol
Myrielle Dupont-Rouzeyrol
OOOlivia O'CONNOR
Olivia O'CONNOR
ECElodie Calvez
Elodie Calvez
MDMaguy Daurès
Maguy Daurès
MJMichéle John
Michéle John
AGAnn-Claire Gourinat
Ann-Claire Gourinat

1 March 2016 in The Lancet
Verified
Journal Article
Closed access
MDMyrielle Dupont-Rouzeyrol
Myrielle Dupont-Rouzeyrol
ABAntoine Biron
Antoine Biron
OOOlivia O'CONNOR
Olivia O'CONNOR
EHEmilie Huguon
Emilie Huguon
EDElodie Descloux
Elodie Descloux

1 September 2007 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
OOOlivia O'CONNOR
Olivia O'CONNOR
MBMarie-France Bosseno
Marie-France Bosseno
CBChristian Barnabé
Christian Barnabé
EDEmmanuel J.P. Douzery
Emmanuel J.P. Douzery
SBSimone Frédérique Brenière
Simone Frédérique Brenière

31 March 2014 in Virology Journal
Verified
Journal Article
Open access
PDF file
MDMyrielle Dupont-Rouzeyrol
Myrielle Dupont-Rouzeyrol
MAMaite Aubry
Maite Aubry
OOOlivia O'CONNOR
Olivia O'CONNOR
CRClaudine Roche
Claudine Roche
AGAnn-Claire Gourinat
Ann-Claire Gourinat
VCVan-Mai Cao-Lormeau
Van-Mai Cao-Lormeau
The epidemiology of dengue in the South Pacific has been characterized by transmission of a single dominant serotype for 3–5 years, with subsequent replacement by another serotype. From 2001 to 2008 only DENV-1 was reported in the Pacific. In 2008, DENV-4 emerged and quickly displaced DENV-1 in the Pacific, except in New Caledonia (NC) where DENV-1 and DENV-4 co-circulated in 2008–2009. During 2012–2013, another DENV-1 outbreak occurred in NC, the third DENV-1 outbreak in a decade. Given that dengue is a serotype-specific immunizing infection, the recurrent outbreaks of a single serotype within a 10-year period was unexpected.

25 June 2014 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
NBNoémie Baroux
Noémie Baroux
EDEric D'ORtenzio
Eric D'ORtenzio
NANathalie Amédéo
Nathalie Amédéo
CBCiara Baker
Ciara Baker
BABarakat Ali Alsuwayyid
Barakat Ali Alsuwayyid
PSPierre Smeesters
Pierre Smeesters
Background. Group A Streptococcus (GAS)–related disease is responsible for high mortality and morbidity in the Pacific region. The high diversity of circulating strains in this region has hindered vaccine development due to apparently low vaccine coverage of type-specific vaccines.